By Aviva Regev
Faculty Peer Reviewed
Introduction
Few people these days are unaware of the “obesity epidemic,†with its inception here in the United States and its steady, insidious spread around the globe. The numbers …
Category: Diseases 2.0
Clinical Correlations
A New Era of Therapy for Hepatitis C
November 4, 2011
By Alexander Jow, MD
Faculty Peer Reviewed
Hepatitis C virus (HCV) is a major public health issue, representing the leading cause of chronic liver disease, death from liver disease, and a principal indication …
Stemming the Tide: The Promise and Pitfalls of HIV Prevention Research
September 28, 2011
By Benjamin Bearnot
Faculty Peer ReviewedÂ
Since the discovery of zidovudine (AZT) in the mid-1980s, advances in antiretroviral (ARV) therapy for patients with chronic human immunodeficiency virus (HIV) infection have, until recently, …
Vegetative State 2.0
May 13, 2011
By Ivan Saraiva, MD
Faculty Peer Reviewed
 “Mr. Dockery was a police officer in the town of Walden, northwest of Chattanooga, when he was shot in the forehead as he …
The Myth of the Helminth: Can Worms be the Next Therapeutic Breakthrough for IBD Patients?
March 16, 2011
By Michael Guss, Class of 2012
Faculty Peer Reviewed
Helminths–parasitic worms that have co-evolved with humans and colonized our gastrointestinal (GI) tract for millennia–have developed the ability to modulate …
Anthracycline Induced Cardiotoxicity
January 14, 2011
By Ami Jhaveri, PGY-3
Faculty Peer Reviewed
Clinical Case:
K.M. is a 61-year-old woman with hypertension diagnosed with non-Hodgkin’s lymphoma 1 month ago. Her only medication is hydrochlorothiazide. …
Kayexalate: What is it and does it work?
December 1, 2010
By Todd Cutler, MD
Faculty Peer Reviewed
A 62-year-old male is hospitalized with an acute congestive heart failure exacerbation. On hospital day three, the patient’s symptoms have significantly …
Proton Pump Inhibitors 2.0
November 26, 2010
By Mary C. Whitman, MD
Faculty Peer Reviewed
Proton pump inhibitors (PPIs) are generally considered “safe†medications[1] and are prescribed to over 100 million patients per year for a variety of indications, often …